1. Recombinant Newcastle disease virus rL-RVG enhances the apoptosis and inhibits the migration of A549 lung adenocarcinoma cells via regulating alpha 7 nicotinic acetylcholine receptors in vitro
   Yulan Yan et al, 2017, Virology Journal CrossRef
2. Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
   Fang Huang et al, 2022, Frontiers in Molecular Biosciences CrossRef
3. eIF2α-CHOP-BCl-2/JNK and IRE1α-XBP1/JNK signaling promote apoptosis and inflammation and support the proliferation of Newcastle disease virus
   Yanrong Li et al, 2019, Cell Death & Disease CrossRef
4. Migration of gastric cancer is suppressed by recombinant Newcastle disease virus (rL-RVG) via regulating α7-nicotinic acetylcholine receptors/ERK- EMT
   Xuefeng Bu et al, 2019, BMC Cancer CrossRef
5. Oncolytic virotherapy in lung cancer
   Estanislao Nistal-Villan et al, 2023, Viral Vectors in Cancer Immunotherapy CrossRef
6. Autophagy is involved in recombinant Newcastle disease virus (rL-RVG)-induced cell death of stomach adenocarcinoma cells in vitro
   XU-FENG BU et al, 2015, International Journal of Oncology CrossRef
7. Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo
   Syed Umar Faruq Syed Najmuddin et al, 2020, Cancer Cell International CrossRef
8. Oncolytic Viruses in Lung Cancer Treatment: A Review Article
   Hanie Sakhi et al, 2024, Immunotherapy CrossRef